Načítá se...

HDAC inhibitors in kidney development and disease

The discovery that histone deacetylase inhibitors (HDACis) can attenuate acute kidney injury (AKI)-mediated damage and reduce fibrosis in kidney disease models has opened the possibility of utilizing HDACis as therapeutics for renal injury. Studies to date have made it abundantly clear that HDACi tr...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Brilli, Lauren L., Swanhart, Lisa M., de Caestecker, Mark P., Hukriede, Neil A.
Médium: Artigo
Jazyk:Inglês
Vydáno: Springer Berlin Heidelberg 2012
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3751322/
https://ncbi.nlm.nih.gov/pubmed/23052657
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00467-012-2320-8
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!